Publication | Closed Access
17-DMCHAG, a new geldanamycin derivative, inhibits prostate cancer cells through Hsp90 inhibition and survivin downregulation
33
Citations
32
References
2015
Year
Survivin DownregulationOncologyMedicineAnti-cancer AgentHsp90 InhibitionCancer TreatmentProstatic DiseaseTumor SuppressorPharmacologyCell BiologyTumor BiologyDrug DiscoveryNew Geldanamycin
| Year | Citations | |
|---|---|---|
Page 1
Page 1